The impact of SARS-CoV2 on the anxiety levels of subjects and on the anxiety and depression levels of their parents
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 47, 102595
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- COVID-19 and Kawasaki Disease: Finding the Signal in the NoiseHospital Pediatrics, 2020
- Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A ReviewFrontiers in Pediatrics, 2020
- Mental health considerations for children quarantined because of COVID-19The Lancet Child & Adolescent Health, 2020
- SARS-CoV-2 Infection in ChildrenNew England Journal of Medicine, 2020
- Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2Journal of Neurology, 2020
- Viral infections and multiple sclerosisDrug Discovery Today: Disease Models, 2020
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysisJournal of the Neurological Sciences, 2017
- Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple SclerosisPaediatric and Perinatal Epidemiology, 2016
- Multiple sclerosis in childhood: Clinical profile in 125 patientsThe Journal of Pediatrics, 1987